NCT00453089View on ClinicalTrials.gov

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Vaginal AtrophyVulvar Atrophy
Interventions
DRUG

VG101

Trial Locations (2)

35294

University of Alabama, Birmingham, Birmingham

94115

University of California, San Francisco, San Francisco

Sponsors

Lead Sponsor

Bionovo
All Listed Sponsors
lead

Bionovo

INDUSTRY

NCT00453089 - VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women | Biotech Hunter | Biotech Hunter